Congresses
The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Jacob S. Ballon, MD, MPH,1 Christina Arevalo, MS,2 Martin Dunbar, PhD,2 Alexandra Lovett, MD,2 David McDonnell, MD,3 Christoph U. Correll, MD4-7
1Stanford University, Stanford, CA; 2Alkermes, Inc., Waltham, MA; 3Alkermes Pharma Ireland Ltd, Dublin, Ireland; 4The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY; 5Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY; 6Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany; 7German Center for Mental Health (DZPG), partner site Berlin, Germany
